2021 News
PharmedOut In the News - 2021
November 2021
November 15: Research Associate Dave Stanke and Dr. Fugh-Berman published, "Cover hearing aids, not questionable Alzheimer's drug," in The Chicago Tribune.
November 22: "Targeting Black and Hispanic communities for dementia drugs," by Caroline Renko and Naisa Rahman was published in the Washington Times. The op-ed exposes how Biogen is targeting Black and Latinx populations for Aduhelm (aducanumab) even though the drug wasn't tested in these populations.
September 2021
September: Dr. Fugh-Berman was a guest on the AMA Journal of Ethics podcast episode, "Ethics Talk: Medical Device Representatives in the Surgical Suite."
September 17: Judy Butler's op-ed, "Caution warranted before using new Alzheimer's drug," exposed marketing messages and misleading claims in Biogen's "educational" website, targeting physicians, on mild cognitive impairment.
August 2021
August 6: Dr. Fugh-Berman was a guest on Connecticut Public Radio’s Where We Live episode, “Opioid Use Disorder: A Growing Epidemic Within An Epidemic.” In this episode, she explained the role of patient advocacy groups in opioid marketing, and dentists' opioid prescription habits
August 21: Dr. Fugh-Berman was interviewed for this story in Kaiser Health News that exposed the close relationships between medical device sales representatives and surgeons.
January 2021
Jan 28: Medscape also published an article on the novel US family residency programs study: "When asked how these trends compare to residencies in other specialties, the authors said that no other research has looked at influence for one specialty over three different time periods."
Jan 19: STAT News published an article on Dr. Steve Brown's and Dr. Fugh-Berman's study on the interactions between pharmaceutical companies and US family residency programs.